PHARMACEUTICAL FOR TREATING FATTY LIVER DISEASES
Provided is a pharmaceutical composition for treating and/or preventing fatty liver disease, particularly nonalcoholic fatty liver disease, the pharmaceutical composition having an excellent ACC2-selective inhibitory action and having no side effects such as an increase in plasma triglyceride or a d...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
05.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided is a pharmaceutical composition for treating and/or preventing fatty liver disease, particularly nonalcoholic fatty liver disease, the pharmaceutical composition having an excellent ACC2-selective inhibitory action and having no side effects such as an increase in plasma triglyceride or a decrease in platelet concentration.A pharmaceutical composition for treating and/or preventing fatty liver disease, the pharmaceutical composition comprising a compound represented by Formula (I):whereinR1 is haloalkyl or non-aromatic carbocyclyl,R2 is a hydrogen atom or halogen,R3 is halogen,ring A is a group represented by the formula: -L1- is -O-(CH2)-, -(CH2)2-, or the like,R4 is alkyl or haloalkyl, andR5 is alkylcarbonyl or carbamoyl,or a pharmaceutically acceptable salt thereof. |
---|---|
Bibliography: | Application Number: EP20210808650 |